Lumexa Imaging (LMRI) Q2 2026 Earnings Call Transcript

Lumexa Imaging Holdings, Inc. (LMRI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lumexa Imaging Announces Second Quarter 2026 Results RALEIGH, N. C., August 12, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated it

Lumexa Imaging (NASDAQ: LMRI) said it formed a strategic joint venture with Hospital for Special Surgery (HSS) to expand advanced outpatient imaging across the New York City metro area. The deal is Lumexa’s ninth joint venture and supports its growth strategy via de novo development, acquisitions, and partnerships. Lumexa reported about 4 million outpatient procedures system-wide in 2025.

Goldman Sachs (GS) reported Q3 2026 net revenues of $18.7B, with record advisory revenues and 72% YoY growth in equities. Asset management revenues rose 14% YoY. Challenges include geopolitical tensions, inflation, and credit quality concerns. CEO David Solomon addressed succession plans, market structure, and AI financing risks. The company maintains a strong capital buffer and expects active Q4 trading. GS's durable revenues now represent 45% of YTD revenues.

Johnson & Johnson (JNJ) reported Q3 2026 operational sales growth of 6%, exceeding expectations. Innovative Medicine grew 7.9%, with key products like TREMFYA and CARVYKTI showing strong sales. The company raised its full-year guidance. However, MedTech grew only 2.5%, and talc litigation expenses impacted GAAP earnings. JNJ expects future growth from pipeline advancements and strategic investments.

Citigroup reported its best Q3 revenue in a decade, but faced challenges like flat consumer cards revenue and expected market revenue declines. Expenses rose 3%, and cost of credit was $2.6 billion. CEO Jane Fraser and CFO Gonzalo Luchetti reaffirmed confidence in exceeding the full-year ROTCE target of above 11% and reiterated near-term targets of 11% to 13% for 2027-2028. The firm is investing in technology and marketing, with $3 billion in buybacks in Q3.

Domino's Pizza Inc (DPZ) reported Q3 2026 earnings, lowering guidance for US and international same-store sales growth, net new store openings, and global retail sales growth due to macroeconomic pressures and franchisee profitability challenges. CEO Joe Jordan discussed strategies to balance promotions, improve ticket growth, and manage delivery channels. The company expects continued pressure on franchisee profits and store development until conditions improve.